Now accepting Telehealth appointments. Schedule a virtual visit.

Preliminary Data Shows How TMS May Treat Depressive Symptoms in Patients with Multiple Sclerosis

Preliminary data presented at the 2022 Annual Meeting of the Consortium of Multiple indicates that TMS may help with the depressive symptoms that people with multiple sclerosis (MS) patients experience. This quantitative study consisting of 20 individuals with MS was conducted to assess the efficacy of using TMS for depression. Their sessions consisted of 10 treatment sessions for 10 consectutive days and aimed to target the primary motor cortex as well as the left dorsolateral prefrontal cortex. Following the treatments, 65% of patients noticed improvements in their depressive symptoms as indicated by Beck Depression Inventory Score. 

This data is instrumental the patients experiencing depressive symptoms associated with MS. The findings indicate the potential use of TMS to treat depressive symptoms for patients with MS. MS patients experience several physical and mental symptoms with depression being a frequent symptom.

Read more about this story here.

You Might Also Enjoy...

988 - A Mental Health Lifeline

988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.

TMS and Its Wide Application

FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.

TMS for Parkinson's Disease

Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.

SAINT Protocol Now Cleared by the FDA

Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).